Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Article Short communication · 19 Jun 2021 Principles of GLP and Compliance Monitoring
rules for good practice and help researchers to perform their work in compliance with OECD-GLP principles using approved study plan and standard operating procedures
Review article · 2018 GLPs, Human Error, and Deviations: When Are Quality and Integrity Compromised?
David V. Gauvin, Scott E. Boley, Noel D. Horton and Theodore J
Rapid communication · 25 Mar 2024 Comparing GLP-1 Agonists: Efficacy, Safety, and Patient Compliance
Article · 14 Sep 2021 Development and validation of analytical method for simultaneous quantitative determination of elemental impurities as p
targeted products. Continuous monitoring of EIs in manufacturing of pharmaceutical products with GLP/GMP compliance in line with regulatory guidelines helps to generate scientific-based risk assessments for over
Review article · 2013 The 7th System: Integrating Clinical Systems into a Comprehensive Quality Audit Program
laboratory operations. This can result in a fractured view of each compliance area (GCP, GMP and GLP) and a failure to provide adequate oversight of an organization’s overall compliance
Conference abstract · 13 Nov 2023 Exploring the potential of vagus nerve neuromodulation as a personalized and enhanced therapeutic experience for Type 2 Diabetics
treatment of type 2 diabetes mellitus (T2DM). However, the therapeutic benefits of GLP-1 are marred by compliance, cost, and side effects. In real-world studies discontinuation rates of GLP
Conference abstract · 2018 A completely novel long-acting GLP-1 receptor agonist, glutazumab
short-acting analogs/receptor agonists have poor compliance in patients for frequent dosing. This study aims to introduce a novel long-acting GLP-1 receptor agonist, which is an antibody
Conference abstract · 5 Dec 2018 Pharmaceuticals regulatory affairs
Corrective action and preventive measure), cGxP (GDP, GLP, GMP) at manufacturing unit, post marketing surveillance/complain, vendor qualification as per regulatory compliance. Regulatory Affairs department is governed
Conference abstract · 20 Sep 2018 Regulatory Affairs
Corrective action and preventive measure), cGxP (GDP, GLP, GMP) at Manufacturing unit, Post marketing surveillance/complain, Vendor qualification as per regulatory compliance. Regulatory Affairs department is governed
Conference abstract · 8 Jun 2018 Regulatory Affairs
Corrective Action and Preventive Measure), cGxP (GDP, GLP, GMP) at manufacturing unit, post marketing surveillance/complain, vendor qualification as per regulatory compliance. Regulatory Affairs department is governed
Conference abstract Pharmaceuticals regulatory affairs
Corrective action and preventive measure), cGxP (GDP, GLP, GMP) at Manufacturing unit, Post marketing surveillance/complain, Vendor qualification as per regulatory compliance. Regulatory Affairs department is governed
Conference abstract · 29 May 2017 Bioengineered nanomedicines for modulation of intestinal anti-diabetic peptide delivery
world with tremendous impact on health worldwide. Anti-diabetic peptides as insulin or GLP-1 are commonly used to treat diabetes in order to give patients a better life condition ... potential to overcome the most…
Article · 2009 DIPEPTIDYL PEPTIDASE-4 INHIBITORS: A NEWAPPROACH IN DIABETES TREATMENT
state of impaired fasting glucose or impaired glucose tolerance to frank diabetes. Despite good compliance to treatment, the glycemic control of type 2 diabetes deteriorates progressively. Hence, new therapeutic agents…
Conference abstract · 12 Nov 2013 A risk based scientific approach to analytical method development and validation activities for regulated laboratories
Topics ? An overview of global compliance issues, global harmonization initiatives, role of ICH, relevance of Validation activities & the Paradigm Shift ? Quality Control and Quality Assurance in analytical ... various…
Conference abstract · 7 Mar 2016 Smart high molecular PEGylated exendin-4 as a noble long-acting type 2 diabetic therapy
Exendin-4, a GLP-1 receptor agonists is viewed as potent therapeutic peptide for type 2 diabetes. Yet due to the short circulating half-life, high doses of the drug ... weekly and monthly dosing frequencies with low…
Article · 18 Oct 2024 Ensuring Quality Medicine: A Comprehensive Overview of EMA and DGDA's History, Structure and Functions
This article provides an in-depth analysis of the European Medicines Agency
Conference abstract · 30 Jun 2016 Novel sustained release formulation of Exenatide in the treatment of type 2 Diabetes and neurodegenerative diseases
type 2 diabetes. Accumulating data also suggest that exenatide as well as other Glp-1R agoinists posess therapeutic potential for the neruodegerative disease such as Alzheimer's disease ... neurodegenerative diseases as…

